Follow us on:
Breaking News
January 14 2026
Breaking News
Breaking News

PSI CRO Opens New Office in Osaka, Japan

 
PSI CRO Opens New Office in Osaka, Japan

Brings sponsors closer to experienced local teams and the local PSI team closer to the established site networks.
Read More >>

Headlines

Breaking News

Johnson & Johnson Announces New Multibillion Dollar Facility in North Carolina

Medicines for oncology and neurological diseases will be produced at the new facility.

SPONSOR

Smarter, Faster, More Reliable (U)HPLC Performance

Built for fast, accurate sample analysis, Shimadzu’s robust integrated HPLC drives productivity and delivers consistent, reliable results.

Breaking News
Financial News

Axol Bioscience Secures $2.8M for U.S. Expansion, Product Development

Financing was led by BroadOak Capital Partners, a U.S. life sciences specialist.

Breaking News
Collaborations & Alliances

Fresenius Kabi, TQ Therapeutics Partner to Advance CGT Accessibility

Under the agreement, TQ Therapeutics’ affinity and column-based cell isolation technology will be integrated into Fresenius Kabi’s Cue Cell Processing System.

SPONSOR

[LIVE EVENT] 2026 CDMO Marketing Trends Report

149 marketing leaders shared their predictions and strategies in the 2026 CDMO Marketing Trends Report. Join Contract Pharma and Altitude Marketing on January 29th to explore the results and share their insight.

IQVIA_eBook_0925_650x250

Breaking News
Collaborations & Alliances

AbbVie, RemeGen Partner on Novel Bispecific Antibody for Advanced Tumors

The investigational PD-1/VEGF-targeted antibody is currently being developed by RemeGen as a monotherapy.

SPONSOR

Speed & Flexibility: The New CDMO Advantage

Pharma’s future demands faster, more agile partners. See how leading CDMOs like ROIS are adapting to shifting market and regulatory needs.

Featured Resources

Solution Center SPOTLIGHT

Almac Group

Almac Group is a global leader in providing a range of expert services and support across the drug development lifecycle. We are trusted experts in R&D, diagnostic services, API manufacture, formulation development, clinical trial supply services and technologies through to commercial-scale manufacture and distribution.

 

Solution Center SPOTLIGHT

LOTTE BIOLOGICS

LOTTE Biologics is a contract development & manufacturing organization delivering integrated biologics & bioconjugate services across the full product lifecycle. Our capabilities encompass phase-appropriate DS manufacturing for mammalian-cell-based biologics, including mAbs, fusion proteins, multispecifics, & integrated ADC manufacturing.